Skip to main content

Table 2 Histological diagnosis in patients with nonseminomas (n=40)

From: Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy

Pure

10 (25.0%)

   Embryonal carcinoma

   8 (20.0%)

   York sac tumor

   1 (2.5%)

   Teratoma

   1 (2.5%)

Mixed

30 (75.0%)

   Teratoma

   21 (52.5%)

   Embryonal carcinoma

   20 (50.0%)

   York sac tumor

   20 (50.0%)

   Seminoma

   19 (47.5%)

   Choriocarcinoma

   7 (17.5%)